<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Traceable Drug Recommendation over Medical Knowledge Graphs - Health AI Hub</title>
    <meta name="description" content="This paper introduces TraceDR, a novel drug recommendation (DR) system built upon medical knowledge graphs (MKGs), designed to address the critical lack of trac">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Traceable Drug Recommendation over Medical Knowledge Graphs</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2510.27274v1" target="_blank">2510.27274v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-10-31
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yu Lin, Zhen Jia, Philipp Christmann, Xu Zhang, Shengdong Du, Tianrui Li
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.IR, cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2510.27274v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2510.27274v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces TraceDR, a novel drug recommendation (DR) system built upon medical knowledge graphs (MKGs), designed to address the critical lack of traceability in existing deep learning-based DR systems. By employing a multi-task learning framework, TraceDR simultaneously predicts medication recommendations and provides explicit evidence for these suggestions, thereby ensuring the derivation process is transparent and explainable. The authors also contribute a new large-scale testbed, DrugRec, for DR, created through an automatic patient health record construction framework, to support more diverse disease and drug scenarios.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Traceability in drug recommendation is paramount for patient safety and clinical trust, allowing healthcare professionals to understand the rationale behind AI-suggested treatments. This system directly supports informed decision-making by providing evidence-based insights, which is crucial in preventing adverse drug events and improving treatment efficacy.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>An AI-powered drug recommendation system designed to assist healthcare professionals in selecting appropriate medications for patients. It leverages medical knowledge graphs and deep learning to provide traceable recommendations, enhancing transparency and trust in AI-driven clinical decision support.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>**Problem Addressed:** Current deep learning-based drug recommendation systems lack transparency and traceability in their decision-making, which is a significant limitation in high-stakes medical applications.</li>
                    
                    <li>**Proposed Solution:** TraceDR, a novel drug recommendation system that operates over a comprehensive medical knowledge graph (MKG) to access high-quality and large-scale medical information.</li>
                    
                    <li>**Core Methodology:** Utilizes a multi-task learning framework that simultaneously predicts drug recommendations and identifies the related evidence from the MKG.</li>
                    
                    <li>**Key Feature:** Enables traceability of medication recommendations by explicitly linking suggestions to the underlying evidence, fostering trust and interpretability.</li>
                    
                    <li>**Data Contribution:** Develops a framework for automatically constructing patient health records to create DrugRec, a new large-scale testbed for drug recommendation.</li>
                    
                    <li>**Scope Expansion:** DrugRec is designed to cover a more diverse range of diseases and drugs compared to existing datasets, enhancing the generalizability of DR research.</li>
                    
                    <li>**Primary Goal:** To improve the safety, reliability, and adoption of AI-driven drug recommendation systems in clinical practice through enhanced explainability.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>TraceDR is a novel drug recommendation system built upon a medical knowledge graph (MKG). It employs a multi-task learning framework to concurrently predict drug recommendations and associated explanatory evidence. A key component is the automatic construction framework for patient health records, which facilitates the creation of a new, large-scale dataset named DrugRec for evaluation and training.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The abstract primarily describes the proposed system's capabilities and contributions rather than explicit results. The main 'findings' are that TraceDR successfully enables traceable drug recommendations by integrating MKGs and multi-task learning for simultaneous prediction of recommendations and supporting evidence. Furthermore, the creation of the DrugRec testbed addresses the need for more diverse and larger-scale datasets in drug recommendation research.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>By providing transparent and evidence-backed drug recommendations, TraceDR can significantly enhance the trust and adoption of AI-powered clinical decision support systems. This transparency allows clinicians to validate recommendations against medical knowledge, potentially leading to safer prescribing practices, reduced medication errors, and more personalized and effective patient care.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract highlights the limitations of *state-of-the-art approaches* (deep learning methods) in providing insights into their derivation process. It does not explicitly state limitations of the proposed TraceDR system itself. The challenge of integrating large, dynamic MKGs and ensuring real-time performance in clinical settings are implicit potential considerations not discussed.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated, potential future directions implied by the work include evaluating TraceDR's real-world clinical effectiveness, exploring its generalizability across different healthcare systems, integrating more complex patient data types (e.g., genomics), and further refining the MKG integration and evidence generation process for even richer explanations.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Clinical Informatics</span>
                    
                    <span class="tag">Pharmacology</span>
                    
                    <span class="tag">Personalized Medicine</span>
                    
                    <span class="tag">Healthcare AI</span>
                    
                    <span class="tag">Medical Decision Making</span>
                    
                    <span class="tag">Health Systems Research</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Drug Recommendation</span>
                    
                    <span class="tag tag-keyword">Medical Knowledge Graph</span>
                    
                    <span class="tag tag-keyword">Traceability</span>
                    
                    <span class="tag tag-keyword">Explainable AI</span>
                    
                    <span class="tag tag-keyword">Multi-task Learning</span>
                    
                    <span class="tag tag-keyword">Healthcare AI</span>
                    
                    <span class="tag tag-keyword">Patient Health Records</span>
                    
                    <span class="tag tag-keyword">Clinical Decision Support</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Drug recommendation (DR) systems aim to support healthcare professionals in
selecting appropriate medications based on patients' medical conditions.
State-of-the-art approaches utilize deep learning techniques for improving DR,
but fall short in providing any insights on the derivation process of
recommendations -- a critical limitation in such high-stake applications. We
propose TraceDR, a novel DR system operating over a medical knowledge graph
(MKG), which ensures access to large-scale and high-quality information.
TraceDR simultaneously predicts drug recommendations and related evidence
within a multi-task learning framework, enabling traceability of medication
recommendations. For covering a more diverse set of diseases and drugs than
existing works, we devise a framework for automatically constructing patient
health records and release DrugRec, a new large-scale testbed for DR.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted to MediKS@CIKM2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>